21-46145457-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_206965.2(FTCD):​c.1220C>A​(p.Thr407Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,560,728 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 16 hom. )

Consequence

FTCD
NM_206965.2 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0310

Publications

5 publications found
Variant links:
Genes affected
FTCD (HGNC:3974): (formimidoyltransferase cyclodeaminase) The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
FTCD Gene-Disease associations (from GenCC):
  • formiminoglutamic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012105256).
BP6
Variant 21-46145457-G-T is Benign according to our data. Variant chr21-46145457-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 340422.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0011 (167/152278) while in subpopulation NFE AF = 0.000985 (67/68014). AF 95% confidence interval is 0.000795. There are 1 homozygotes in GnomAd4. There are 83 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FTCDNM_206965.2 linkc.1220C>A p.Thr407Lys missense_variant Exon 10 of 14 ENST00000397746.8 NP_996848.1
FTCDNM_001320412.2 linkc.1220C>A p.Thr407Lys missense_variant Exon 10 of 15 NP_001307341.1
FTCDNM_006657.3 linkc.1220C>A p.Thr407Lys missense_variant Exon 10 of 15 NP_006648.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FTCDENST00000397746.8 linkc.1220C>A p.Thr407Lys missense_variant Exon 10 of 14 1 NM_206965.2 ENSP00000380854.3

Frequencies

GnomAD3 genomes
AF:
0.00110
AC:
167
AN:
152160
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.0225
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000985
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00200
AC:
337
AN:
168516
AF XY:
0.00190
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000704
Gnomad ASJ exome
AF:
0.0235
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00141
Gnomad OTH exome
AF:
0.00351
GnomAD4 exome
AF:
0.00136
AC:
1910
AN:
1408450
Hom.:
16
Cov.:
32
AF XY:
0.00135
AC XY:
943
AN XY:
696084
show subpopulations
African (AFR)
AF:
0.000187
AC:
6
AN:
32002
American (AMR)
AF:
0.000814
AC:
31
AN:
38082
Ashkenazi Jewish (ASJ)
AF:
0.0226
AC:
569
AN:
25218
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36318
South Asian (SAS)
AF:
0.000175
AC:
14
AN:
79916
European-Finnish (FIN)
AF:
0.0000631
AC:
3
AN:
47526
Middle Eastern (MID)
AF:
0.00546
AC:
31
AN:
5682
European-Non Finnish (NFE)
AF:
0.00102
AC:
1102
AN:
1085346
Other (OTH)
AF:
0.00264
AC:
154
AN:
58360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
97
195
292
390
487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
167
AN:
152278
Hom.:
1
Cov.:
31
AF XY:
0.00112
AC XY:
83
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41560
American (AMR)
AF:
0.000915
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0225
AC:
78
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000985
AC:
67
AN:
68014
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00201
Hom.:
5
Bravo
AF:
0.00120
ESP6500AA
AF:
0.000235
AC:
1
ESP6500EA
AF:
0.00201
AC:
17
ExAC
AF:
0.000924
AC:
106
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FTCD: BP4

Glutamate formiminotransferase deficiency Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.1
DANN
Benign
0.41
DEOGEN2
Benign
0.044
T;.;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.085
N
LIST_S2
Benign
0.0
.;T;T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.56
N;N;N;.
PhyloP100
-0.031
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.13
N;N;N;N
REVEL
Benign
0.041
Sift
Benign
0.93
T;T;T;T
Sift4G
Benign
0.88
T;T;T;T
Vest4
0.18
ClinPred
0.014
T
GERP RS
0.91
Varity_R
0.031
gMVP
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148920158; hg19: chr21-47565371; API